Pharmatech Appoints COO

Krystyna Kowalczyk has been appointed chief operating officer at Pharmatech. She reports to chief executive officer Rob Bohacs. Ms. Kowalczyk will work to enhance operations and is expected to further enhance the company’s focus and therapeutic expertise surrounding clinical oncology trials.
 
“We are excited and honored to welcome Ms. Kowalczyk to our organization,” said Mr. Bohacs. “Her passion for clinical research and experience in clinical trial management will ensure that we have a premier operations team. Her background in CRO and Site Management services will add value and vision to Pharmatech’s management of our oncology network and our mission to increase patient enrollment in oncology clinical trials. She will be an invaluable asset to us.”
 
Ms. Kowalczyk joins the company from Novella Clinical, where she was executive vice president of Clinical Operations. She has more than 25 years of experience as a clinical research professional with a strong background in organizational development, financial management, corporate leadership, operational strategy, project management, and customer management in the CRO sector.